重组Anti-RSK1 p90抗体[E4]
Anti-RSK1 p90 antibody [E4]
- RabMAb
- Recombinant
- KO Validated
- 了解详情
5
(4 Reviews)
|
(16 Publications)
Rabbit Recombinant Monoclonal RSK1 p90 antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra), IHC-P and reacts with Human, Mouse, Rat samples. Cited in 16 publications.
查看别名
MAPKAPK1A, RSK1, RPS6KA1, Ribosomal protein S6 kinase alpha-1, S6K-alpha-1, 90 kDa ribosomal protein S6 kinase 1, MAP kinase-activated protein kinase 1a, Ribosomal S6 kinase 1, p90-RSK 1, p90RSK1, p90S6K, MAPK-activated protein kinase 1a, MAPKAP kinase 1a, MAPKAPK-1a, RSK-1
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RSK1 p90 antibody [E4] (AB32114)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human breast cancer tissue sections labeling RSK1 p90 with purified ab32114 at 1/100 dilution (15.4 μg/ml). Heat mediated antigen retrieval was performed using heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0). ImmunoHistoProbe one step HRP Polymer (ready to use) was used as the secondary antibody. Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-RSK1 p90 antibody [E4] (AB32114)
Intracellular Flow Cytometry analysis of HeLa (Human cervix adenocarcinoma epithelial cell) cells labeling RSK1 p90 with purified ab32114 at 1/150 dilution (10μg/ml) (red). Cells were fixed with 4% Paraformaldehyde and permeabilised with 90% Methanol. A Goat anti rabbit IgG (Alexa Fluorr® 488, ab150077) secondary antibody was used at 1/2000. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-RSK1 p90 antibody [E4] (AB32114)
Overlay histogram showing HeLa cells stained with (unpurified)ab32114 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab32114, 1/1000 dilution) for 30 min at 22°C. The secondary antibody used was Alexa Fluor® 488 goat anti-rabbit IgG (H&L) (ab150077) at 1/2000 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (0.1μg/1x106 cells) used under the same conditions. Unlabelled sample (blue line) was also used as a control. Acquisition of >5,000 events were collected using a 20mW Argon ion laser (488nm) and 525/30 bandpass filter. This antibody gave a positive signal in HeLa cells fixed with 4% paraformaldehyde (10 min)/permeabilized with 0.1% PBS-Tween for 20 min used under the same conditions.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-RSK1 p90 antibody [E4] (AB32114)
Immunocytochemistry/ Immunofluorescence analysis of K-562 (Human chronic myelogenous leukemia lymphoblast) cells labeling RSK1 p90 with purified ab32114 at 1/150 dilution (10 μg/ml). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) at 1 : 200 (2.5 μg/ml). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) was used as the secondary antibody at 1/1000 (2 μg/ml) dilution. DAPI (blue) was used as nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RSK1 p90 antibody [E4] (AB32114)
ab32114 (unpurified), at a 1/100 dilution, staining RSK1 p90 in paraffin embedded human colon tissue by immunohistochemistry.
- IP
Unknown
Immunoprecipitation - Anti-RSK1 p90 antibody [E4] (AB32114)
ab32114 (purified) at 1/70 dilution (2ug) immunoprecipitating RSK1 p90 in K-562 whole cell lysate. K-562 (Human chronic myelogenous leukemia lymphoblast) whole cell lysate 10ug
Lane 2 (+) : ab32114 & K-562 whole cell lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab32114 in K-562 whole cell lysate
For western blotting, VeriBlot for IP secondary antibody (HRP) (ab131366) was used at 1/1000 dilution.
Blocking and diluting buffer : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-RSK1 p90 antibody [E4] (ab32114)
Predicted band size: 82 kDa
false
- WB
Lab
Western blot - Anti-RSK1 p90 antibody [E4] (AB32114)
Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : RSK1 p90 knockout HAP1 cell lysate (20 μg)
Lane 3 : MCF7 cell lysate (20 μg)
Lane 4 : K562 cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab32114 (unpurified) observed at 88 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab32114 was shown to recognize RSK1 p90 when RSK1 p90 knockout samples were used, along with additional cross-reactive bands. Wild-type and RSK1 p90 knockout samples were subjected to SDS-PAGE. ab32114 and ab8245 (loading control to GAPDH) were diluted at 1/500 and 1/10 000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10 000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-RSK1 p90 antibody [E4] (ab32114)
Predicted band size: 82 kDa
false
- WB
Lab
Western blot - Anti-RSK1 p90 antibody [E4] (AB32114)
Western blot : Anti-RSK1 p90 antibody [E4] ab32114 staining at 1/500 dilution, shown in green; Mouse anti GAPDH (ab8245) loading control staining at 1/20,000 dilution, shown in magenta. A band was observed at 83 kDa in Wild-type MCF7 cell lysates with no signal observed at this size in RPS6KA1 knockout MCF7 cell line. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3pc Milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20,000 dilution.
All lanes:
Western blot - Anti-RSK1 p90 antibody [E4] (ab32114) at 1/500 dilution
Lane 1:
Wild-type MCF7 at 20 µg
Lane 2:
Western blot - Human RPS6KA1 knockout MCF7 cell line (ab289311) at 20 µg
Lane 3:
PC-3 at 20 µg
Lane 4:
Calu-3 at 20 µg
Secondary
Lanes 1 - 4:
Goat anti-Rabbit 800CW at 1/20000 dilution
Lanes 1 - 4:
Goat anti-Mouse 680RD at 1/20000 dilution
Predicted band size: 83 kDa
Observed band size: 83 kDa,37 kDa
false
- WB
Lab
Western blot - Anti-RSK1 p90 antibody [E4] (AB32114)
All lanes:
Western blot - Anti-RSK1 p90 antibody [E4] (ab32114) at 1/1000 dilution
Lane 1:
MCF7 (Human breast adenocarcinoma epithelial cell) whole cell lysates at 20 µg
Lane 2:
K-562 (Human chronic myelogenous leukemia lymphoblast) whole cell lysate at 20 µg
Lane 3:
Mouse lung lysates at 20 µg
Lane 4:
PC-12 (Rat adrenal gland pheochromocytoma) whole cell lysates at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 82 kDa
Observed band size: 83 kDa
false
- WB
Unknown
Western blot - Anti-RSK1 p90 antibody [E4] (AB32114)
All lanes:
Western blot - Anti-RSK1 p90 antibody [E4] (ab32114) at 1/1000 dilution
All lanes:
MCF7 cell lysate at 10 µg
Predicted band size: 82 kDa
Observed band size: 90 kDa
false
不同偶联物与剂型 (10)
-
Anti-RSK1 p90 antibody [E4] - BSA and Azide free
-
578 PE
PE Anti-RSK1 p90 antibody [E4]
-
HRP Anti-RSK1 p90 antibody [E4]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-RSK1 p90 antibody [E4]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-RSK1 p90 antibody [E4]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-RSK1 p90 antibody [E4]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-RSK1 p90 antibody [E4]
-
660 APC
APC Anti-RSK1 p90 antibody [E4]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-RSK1 p90 antibody [E4]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-RSK1 p90 antibody [E4]
反应性数据
产品详情
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存时间
推荐的短期储存条件
推荐的长期储存条件
分装信息
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
RSK1 plays a fundamental role in cell proliferation and differentiation in the context of the p90 protein weight. It is an important component of the mitogen-activated protein kinase (MAPK) signaling pathway and forms part of multi-protein complexes that facilitate its activation and function. RSK1 influences various biological processes by phosphorylating transcription factors histone proteins and other kinases thereby regulating gene expression and protein synthesis. These actions highlight its influence in maintaining cellular homeostasis.
Pathways
RSK1 p90 interacts significantly with the MAPK/ERK and PI3K/AKT pathways. It acts downstream of ERK where it receives activating signals that enable it to phosphorylate substrates within the cell. This role supports its interaction with proteins like Akt and mTOR which are critical mediators of cell growth signals. The interplay between these pathways enables cells to respond to growth factors and stress contributing to the regulation of development and metabolism.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (16)
Recent publications for all applications. Explore the full list and refine your search
BMC cancer 24:1189 PubMed39333927
2024
Applications
Unspecified application
Species
Unspecified reactive species
Leukemia 37:1611-1625 PubMed37414921
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell 41:853-870.e13 PubMed37084735
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in public health 10:1002029 PubMed36238249
2022
Applications
Unspecified application
Species
Unspecified reactive species
Oncology reports 46: PubMed34296285
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 23: PubMed33760179
2021
Applications
Unspecified application
Species
Unspecified reactive species
Technology in cancer research & treatment 19:1533033820957006 PubMed33000678
2020
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 22:4619-4628 PubMed33173986
2020
Applications
Unspecified application
Species
Unspecified reactive species
International journal of oncology 55:684-696 PubMed31322183
2019
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 39:1215-1231 PubMed30334662
2018
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com